Dec 21, 2023
1:8
For every 8 shares held, investors received 1. The price per share adjusted from $0.44 to $0.05.
The split itself did not change the total investment value.
NeuroBo Pharmaceuticals, Inc. (NRBO) trades on the NASDAQ Capital Market in the Biotechnology industry.
NeuroBo Pharmaceuticals, Inc. company overviewThe latest split shown was on December 21, 2023. It was a 1-for-8 reverse split, so shareholders received 1 share for every 8 they held.
This history records 3 reverse splits between December 31, 2019 and December 21, 2023.